Bio2 Technologies
-
Biologics
Bio2 Technologies Enrolls First Vitrium Patient in Cervical Spine Fusion Trial
WOBURN, Mass., Aug. 5, 2019 /PRNewswire/ — Bio2 Technologies, Inc., the developer of Vitrium, a unique proprietary structural and resorbable orthobiomaterial, announced the…
Read More » -
Biologics
Bio2 Technologies, Inc. to Present Results from Ovine Spinal Fusion Study
WOBURN, Mass., March 8, 2017 /PRNewswire/ — Bio2 Technologies will present a poster at the Annual Meeting of the Orthopaedic…
Read More »